Khrystany T. Isebia

Dr. Molewaterplein 40
Rotterdam, ZH 3015GD, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Expression patterns of potential targets for antibody-directed therapy in metastatic castration-resistant prostate cancer patients.

Expression patterns of potential targets for antibody-directed therapy in metastatic castration-resistant prostate cancer patients.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 01, 2026

Clinical Trial Protocol for the Apa/Enza-short Study: A Randomized Nationwide Study of Shortened 12-Month Duration of Androgen Receptor Signaling Agent in Combination With Androgen Deprivation Therapy in Patients With Metastatic Low-volume Castration-sensitive Prostate Cancer.

Clinical Trial Protocol for the Apa/Enza-short Study: A Randomized Nationwide Study of Shortened 12-Month Duration of Androgen Receptor Signaling Agent in Combination With Androgen Deprivation Therapy in Patients With Metastatic Low-volume Castration-sensitive Prostate Cancer.

Journal: European urology focus

Published: December 03, 2025

PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients.

PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients.

Journal: Cancer research communications

Published: March 19, 2025

Cell-free DNA aneuploidy score as a dynamic early response marker in prostate cancer.

Cell-free DNA aneuploidy score as a dynamic early response marker in prostate cancer.

Journal: Molecular oncology

Published: July 25, 2024

Low nailfold capillary density in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: biomarker of clinical outcome?

Low nailfold capillary density in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: biomarker of clinical outcome?

Journal: Scientific reports

Published: April 05, 2024

Liquid Biopsies for Early Response Evaluation of Radium-223 in Metastatic Prostate Cancer.

Liquid Biopsies for Early Response Evaluation of Radium-223 in Metastatic Prostate Cancer.

Journal: JCO precision oncology

Published: December 07, 2023

Identification of functional and diverse circulating cancer-associated fibroblasts in metastatic castration-naïve prostate cancer patients.

Identification of functional and diverse circulating cancer-associated fibroblasts in metastatic castration-naïve prostate cancer patients.

Journal: Molecular oncology

Published: November 15, 2023

Flow-based immunomagnetic enrichment of circulating tumor cells from diagnostic leukapheresis product.

Flow-based immunomagnetic enrichment of circulating tumor cells from diagnostic leukapheresis product.

Journal: Molecular oncology

Published: September 26, 2023

Early Identification of Patients at Risk of Cabazitaxel-induced Severe Neutropenia.

Early Identification of Patients at Risk of Cabazitaxel-induced Severe Neutropenia.

Journal: European urology oncology

Published: August 10, 2023

Improved enrichment of circulating tumor cells from diagnostic leukapheresis product.

Improved enrichment of circulating tumor cells from diagnostic leukapheresis product.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Published: May 09, 2023

A Compendium of AR Splice Variants in Metastatic Castration-Resistant Prostate Cancer.

A Compendium of AR Splice Variants in Metastatic Castration-Resistant Prostate Cancer.

Journal: International journal of molecular sciences

Published: January 31, 2023

mFast-SeqS-based aneuploidy score in circulating cell-free DNA is a prognostic biomarker in prostate cancer.

mFast-SeqS-based aneuploidy score in circulating cell-free DNA is a prognostic biomarker in prostate cancer.

Journal: Molecular oncology

Published: January 19, 2023

Showing 1-12 of 16

Last Updated: 09/26/2026